Tri Locum Partners’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,527
Closed -$50K 74
2022
Q4
$50K Buy
+18,527
New +$54K 0.02% 55

Other funds holding ORGO

Tri Locum Partners's ORGO Position: Q1 2023 in Review

Tri Locum Partners sold out of Organogenesis Holdings (ORGO) in Q1 2023, closing a stake of 18,527 shares — an estimated $50K sold.

Tri Locum Partners first reported a position in ORGO in Q4 2022 and held it in 1 quarter. The position peaked at $50K in Q4 2022. 131 funds tracked by Wall St. Rank hold ORGO as of Q1 2023.

  • Tri Locum Partners reported no remaining Organogenesis Holdings position as of Q1 2023 after selling out during the quarter.
  • Tri Locum Partners sold 18,527 Organogenesis Holdings shares in Q1 2023, an estimated $50K.
  • Tri Locum Partners first reported a position in Organogenesis Holdings in Q4 2022 and held it in 1 quarter.
  • Tri Locum Partners's Organogenesis Holdings position peaked at $50K in Q4 2022.
  • 131 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2023.

Based on Tri Locum Partners's 13F filing for Q1 2023, filed 15 May 2023.